Subcomponent Vaccine Based on CTA1-DD Adjuvant with Incorporated UreB Class II Peptides Stimulates Protective Helicobacter pylori Immunity

• John G. Nedrud,

  Affiliation Department of Pathology, Case Western Reserve University, Cleveland, Ohio, United States of America

  ⨯
• Nayer Bagheri,

  Affiliation Department of Pathology, Case Western Reserve University, Cleveland, Ohio, United States of America

  ⨯
• Karin Schön,

  Affiliation Mucosal Immunobiology and Vaccine Research Center (MIVAC) and the Department of Microbiolgy and Immunology, Institute of Biomedicine, University of Gothenburg, Göteborg, Sweden

  ⨯
• Wei Xin,

  Affiliation Department of Pathology, Case Western Reserve University, Cleveland, Ohio, United States of America

  ⨯
• Hilda Bergroth,

  Affiliation Mucosal Immunobiology and Vaccine Research Center (MIVAC) and the Department of Microbiolgy and Immunology, Institute of Biomedicine, University of Gothenburg, Göteborg, Sweden

  ⨯
• Dubravka Grdic Eliasson,

  Affiliation Mucosal Immunobiology and Vaccine Research Center (MIVAC) and the Department of Microbiolgy and Immunology, Institute of Biomedicine, University of Gothenburg, Göteborg, Sweden

  ⨯
• Nils Y. Lycke

  * E-mail: nils.lycke@microbio.gu.se

  Affiliation Mucosal Immunobiology and Vaccine Research Center (MIVAC) and the Department of Microbiolgy and Immunology, Institute of Biomedicine, University of Gothenburg, Göteborg, Sweden

  ⨯